THE ANTES B+ STUDY: AN OPEN-LABEL, PRAGMATIC,RANDOMIZED, CONTROLLED TRIAL OF TRIPLE THERAPYVERSUS LABA-LAMA COMBINATION TO IMPROVE CLINICALCONTROL IN HIGH-RISK GOLD B PATIENTS (B+)

• Protocol code: ANTES B
• EudraCT code: No aplica
• Research group: Pneumology
• Service: Pneumology
• Principal investigator:  Miravitlles Fernández, Marc
• Pathology: Malalties del sistema respiratori
• Phase: Fase IV